Lazard Asset Management
ACIU icon

Lazard Asset Management’s AC Immune ACIU Stock Holding History

Lazard Asset Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-813
Closed -$1K – 2277
2025
Q1 		$1K Buy
813
+56
+7% +$141 ﹤0.01% 2219
2024
Q4 		$2K Buy
+757
New +$2.37K ﹤0.01% 2176
2024
Q2 		– Sell
-10,260
Closed -$30K – 2205
2024
Q1 		$30K Buy
+10,260
New +$36.8K ﹤0.01% 1801
2020
Q3 		– Sell
-5,741
Closed -$38K – 1596
2020
Q2 		$38K Sell
5,741
-526
-8% -$3.82K ﹤0.01% 1290
2020
Q1 		$43K Buy
6,267
+4,328
+223% +$33.8K ﹤0.01% 1228
2019
Q4 		$16K Buy
+1,939
New +$12.9K ﹤0.01% 1282

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Lazard Asset Management's ACIU Position: Q2 2025 in Review

Lazard Asset Management sold out of AC Immune (ACIU) in Q2 2025, closing a stake of 813 shares — an estimated $1K sold.

Lazard Asset Management first reported a position in ACIU in Q4 2019 and held it in 6 quarters. The position peaked at $43K in Q1 2020. 42 funds tracked by Wall St. Rank hold ACIU as of Q2 2025.

  • Lazard Asset Management reported no remaining AC Immune position as of Q2 2025 after selling out during the quarter.
  • Lazard Asset Management sold 813 AC Immune shares in Q2 2025, an estimated $1K.
  • Lazard Asset Management first reported a position in AC Immune in Q4 2019 and held it in 6 quarters.
  • Lazard Asset Management's AC Immune position peaked at $43K in Q1 2020.
  • 42 funds tracked by Wall St. Rank held AC Immune as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.